The funding will help researchers better understand how a person tips over from gluten tolerance to celiac disease, and for understanding how autoimmune disorders develop in infants.
Maureen Leonard, MD
Maureen Leonard, MD
Assistant Professor of Pediatrics, Harvard Medical School
Departments, Centers, & Programs:
Mass General for Children: Pediatric Gastroenterology & Nutrition Program
55 Fruit St.
Yawkey Center for Outpatient Care
Boston, MA 02114
- MD, New York Medical College
- Residency, Tufts Medical Center
- Fellowship, Massachusetts General Hospital
American Board Certifications
- Pediatric Gastroenterology, American Board of Pediatrics
- Pediatrics, American Board of Pediatrics
Accepted Insurance Plans
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Dr. Leonard’s research is focused on predicting and preventing celiac disease through precision medicine. Precision medicine is an emerging approach to disease prevention and treatment that takes into account individual variability in genes, environment, and lifestyle.
Her current work includes identifying biomarkers that can predict intestinal healing in patients with celiac disease, building translational models capable of predicting autoimmune disease in high-risk individuals and working with Dr. Alessio Fasano on the NIH-funded Celiac Disease: Genomic Environment Microbiome and Metabolomic Study (CDGEMM).
Dr. Leonard currently holds funding from the NIH (K23DK122127) and was previously funded by the Thrasher Research Fund, the Nutrition Obesity Research Center at Harvard, and the NIH (FDK109620A).
Related News and Articles
- Jun | 26 | 2023
The Center for Celiac Research and Treatment at Mass General for Children provides programs and positive messaging to educate the public and debunk common myths about celiac disease.
- Aug | 10 | 2021
In this presentation from August 10, 2021, Maureen Leonard, MD, MMSc, and Stephanie Harshman, PhD, RD, LD, from the Center for Celiac Research and Treatment at Mass General for Children discuss the two most common gluten related disorders—celiac disease and non-celiac gluten sensitivity.
- Oct | 9 | 2020
The first publication of CDGEMM Study results has been published, open access, in Microbiome. Mass General for Children's Dr. Maureen Leonard shares what the CDGEMM team has learned thus far about celiac disease development by studying infants at risk of celiac disease.
- Nov | 19 | 2019
Celiac Disease Researchers Link Early-Life Environmental Triggers with Changes in the Developing Gut Microbiome
Maureen Leonard, MD, MMSc, lead study author and clinical director of the Center for Celiac Research and Treatment at Mass General for Children (MGfC), has been studying infants at risk of celiac disease for the last seven years.
- Patient Education
- Oct | 7 | 2019
The CDGEMM Study enrolls infants who have a parent or sibling diagnosed with CD. The risk of developing CD for these infants is increased by 8-25% over that of the general population. Enrolled children are followed from birth until they reach five years of age.